Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Gilead Sciences, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
GILD
Nasdaq
2834
https://www.gilead.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Gilead Sciences, Inc.
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
- Apr 24th, 2024 1:19 pm
Incyte (INCY) Earnings Expected to Grow: Should You Buy?
- Apr 23rd, 2024 2:01 pm
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
- Apr 22nd, 2024 5:57 pm
Insights Into Gilead (GILD) Q1: Wall Street Projections for Key Metrics
- Apr 22nd, 2024 1:16 pm
Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know
- Apr 19th, 2024 9:50 pm
US FDA mandates label updates on CAR-T cancer therapies
- Apr 18th, 2024 10:33 pm
Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
- Apr 18th, 2024 10:00 pm
Gilead Sciences Publishes 2023 ESG Impact Report
- Apr 18th, 2024 5:45 pm
Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
- Apr 18th, 2024 2:01 pm
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA
- Apr 17th, 2024 6:03 am
Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
- Apr 16th, 2024 1:14 pm
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
- Apr 16th, 2024 1:00 pm
Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?
- Apr 15th, 2024 12:00 pm
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY-LED INITIATIVES IN ASIA
- Apr 15th, 2024 5:06 am
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY LED INITIATIVES IN HONG KONG
- Apr 15th, 2024 4:22 am
Gilead Sciences (GILD) Stock Moves -0.84%: What You Should Know
- Apr 12th, 2024 10:00 pm
12 Best Depressed Stocks To Buy in 2024
- Apr 10th, 2024 10:09 pm
Gilead Sciences (GILD) Exceeds Market Returns: Some Facts to Consider
- Apr 9th, 2024 10:15 pm
3 Stocks at 52-Week Lows Poised for a Powerful Rebound
- Apr 9th, 2024 6:40 pm
11 Best Biotech ETFs To Buy
- Apr 9th, 2024 11:37 am
Scroll